Skip to main content
Contact
Biotechnology & Life Sciences
Cross-Border Finance Operations

Accounting, Taxation & Reporting for US & India Operations

How MYND established a small Shared Service Center (SSC) for a US-based Biotechnology Research Company, delivering end-to-end accounting, US GAAP compliance, and consolidated financial reporting across two countries.

Service Scope
Book Keeping Accounting Taxation Reporting
Engagement Snapshot
3 Team Members
10+ Years & Running
2 Countries Served
US GAAP Compliance Standard
ERP Systems:
Industry Background

The Unique Financial Challenges of Biotechnology Research Companies

The biotechnology and life sciences sector operates at the intersection of scientific innovation and complex regulatory frameworks. Companies in this space face unique financial management challenges that extend beyond typical business operations. Research-intensive organizations often manage multi-year projects with varying funding cycles, grant-based revenue streams, and intricate compliance requirements across multiple jurisdictions.

For US-based biotech firms with international operations, particularly in research hubs like India, the complexity multiplies. These organizations must navigate different accounting standards (US GAAP vs. Indian GAAP), manage currency fluctuations, ensure compliance with both US SEC requirements and Indian statutory regulations, and maintain consolidated financial visibility across entities operating in vastly different regulatory environments.

Small to mid-sized biotechnology companies often lack the in-house resources to build dedicated finance teams capable of handling these cross-border complexities, yet they require the same level of financial accuracy and compliance rigor as larger pharmaceutical corporations. This creates a critical gap that strategic outsourcing partnerships can effectively bridge.

Cross-Border Complexity

Managing financial operations across US and India requires expertise in multiple accounting standards, tax treaties, and regulatory frameworks.

US GAAP Compliance

Biotechnology companies must adhere to stringent US GAAP requirements for revenue recognition, R&D capitalization, and grant accounting.

Consolidation Requirements

Multi-entity structures demand seamless consolidation of financial records with proper intercompany eliminations and currency translation.

Resource Constraints

Research-focused organizations prefer investing in core scientific capabilities rather than building large back-office finance teams.

How can we help you today?

0/500

Tell us a bit about yourself

Preferred way to contact you?

The Need

Critical Challenges Facing the Client

The US-based biotechnology research company approached MYND with a complex set of financial management challenges that were hindering their ability to focus on core research activities and maintain regulatory compliance.

1

Calendar Year & US GAAP Financials

The client required preparation of financials based on the calendar year and US GAAP standards. Their existing records were maintained on different fiscal cycles and accounting standards, creating significant challenges for investor reporting and regulatory compliance in the United States.

2

Lack of In-House Expertise

The company lacked the specialized expertise to prepare financials in-house. As a research-focused organization, their core competencies were in biotechnology innovation, not in navigating the complexities of cross-border accounting, US GAAP compliance, and multi-currency financial reporting.

3

Consolidation with US Entity

The client needed seamless consolidation of books of records with the US entity. This involved complex intercompany transactions, currency translation adjustments, elimination entries, and unified reporting that provided a clear picture of the combined organization's financial position.

4

End-to-End Multi-Entity Accounting

The organization required end-to-end accounting for both India and US entities under a single, coordinated framework. This meant managing two different regulatory environments, tax regimes, and compliance requirements while maintaining consistency and accuracy across both operations.

Our Solution

MYND's Strategic Approach

MYND designed and implemented a comprehensive solution that addressed each of the client's challenges through a phased approach, starting with a critical one-time project that evolved into a long-term partnership.

Phase 1
One-Time Project

Historical Financial Conversion

Executed a one-time project to convert 3 years of financials to calendar year format and translate all records into US currency. This critical foundation project involved detailed analysis of historical transactions, proper period cutoffs, and accurate currency translation using appropriate exchange rates for each reporting period.

Deliverable: 3 years of US GAAP compliant financials ready for consolidation

Phase 2
Engagement Expansion

Complete Accounting Mandate

Based on the successful completion of the one-time project, the client awarded MYND the complete accounting mandate for both India and US entities, including the consolidation. This expanded scope demonstrated the trust built through quality delivery and positioned MYND as the client's strategic finance partner.

Outcome: 10+ year ongoing partnership established

Phase 3
Ongoing Operations

Dual-Entity Service Delivery

Established comprehensive service delivery covering Book Keeping & Reporting and Taxation for the India entity, along with Book Keeping & Reporting for the US entity. This dual-track approach ensures both entities receive specialized attention while maintaining consistency for consolidation purposes.

Scope: Full-service F&A for India + Reporting for US entity

Phase 4
SLA Framework

End-to-End SLA Management

Implemented a robust end-to-end solution to manage all transactions under a defined SLA framework. This includes clear turnaround times for transaction processing, monthly close timelines, reporting deadlines, and escalation protocols to ensure consistent, reliable service delivery.

Framework: Defined KPIs, monthly reviews, continuous improvement

Benefits for Client

Transformative Business Outcomes

The partnership with MYND delivered measurable improvements across the client's financial operations, enabling them to focus on their core biotechnology research while maintaining world-class financial management.

Process Standardization

Implemented consistent accounting processes across both US and India entities, ensuring uniform treatment of transactions, standardized chart of accounts, and harmonized reporting formats that simplify consolidation and analysis.

Single/Centralized SPOC

Established a single point of contact for all finance-related matters across both entities. This centralized approach eliminates coordination overhead, ensures consistent communication, and provides the client with streamlined access to all financial information.

Highly Scalable Back-End Team

Provided a highly scalable back-end team capable of meeting the demands of a fast-growing business environment. As the client's research activities expand, MYND's team scales seamlessly without the client needing to manage recruitment or training.

Superior Cost Efficiency

Working with MYND proved more cost efficient than trying to recruit equivalent expertise in-house. The client avoids fixed costs of full-time finance staff, benefits from shared infrastructure, and gains access to specialized skills without premium salary requirements typical of cross-border accounting professionals.

Access to Expert & Trained Team

Gained access to an expert and trained team with deep knowledge of US GAAP, Indian accounting standards, cross-border taxation, and biotechnology industry requirements. This expertise would be difficult and expensive to build internally.

Engagement Summary

A Decade of Trusted Partnership

What began as a focused project to convert historical financials has evolved into a decade-long strategic partnership. MYND's small but expert Shared Service Center continues to deliver reliable, accurate financial management for the client's cross-border operations, allowing their scientists and researchers to focus entirely on breakthrough biotechnology innovations.

This engagement exemplifies MYND's approach to client relationships: start by solving an immediate challenge with excellence, then expand the partnership based on proven results. The 10+ year duration of this relationship speaks to the consistent value delivered and the deep trust established between both organizations.

"A successful outsourcing partnership isn't measured by the size of the team, but by the quality of outcomes delivered. Three dedicated professionals, armed with the right expertise and supported by robust processes, can transform financial operations for global organizations."

— MYND Delivery Excellence Philosophy

Partnership at a Glance

US-Based Biotechnology Research Company

3 Team Members
10+ Years Running
2 Countries
2 ERP Systems

Services Delivered

Book Keeping Accounting Taxation (India) Financial Reporting Consolidation US GAAP Compliance

Transform Your Cross-Border Finance Operations

Whether you're a biotechnology company, research organization, or any enterprise managing multi-country operations, MYND's expert team can deliver the same transformative results. Let us handle your Finance & Accounting complexities while you focus on what you do best.

Schedule Free Consultation View More Case Studies
1000+ Enterprise Clients
22+ Years Proven Excellence
ISO Certified 27001 & 27701
All Case Studies